Long-Term Safety Unknowns The available human CJC-1295 studies are limited and mostly involve the DAC-modified form
It helps keep the levels of free radicals in the body in check to reduce inflammation
Clinical trials Although several studies using in vitro and in vivo experimental models have reported the protective effects of polyphenols in CFS and muscle atrophies, human use is still scarce in this area, perhaps due to ambiguities in polyphenol bioavailability, doses, and lack of efficacy in humans (Nikawa et al
D51.3 - Other dietary vitamin B12 deficiency anemia: Used when macrocytic anemia is related to dietary vitamin B12 deficiency, not specifically due to malabsorption issues
Its unique profile (native gastric peptide, stable without carriers, effective at nanogram doses, modulating multiple interconnected neurotransmitter systems simultaneously, promoting actual neuronal repair rather than just symptomatic relief) distinguishes it from all existing psychiatric medications
Low SAM, excessive methylation demand, impaired creatine synthesis, reduced glutathione availability and oxidative stress may place additional strain on mitochondria, potentially contributing to fatigue, variable cognitive stamina, sensory sensitivity, poor stress tolerance and slow recovery from illness
